Opportunities in the pharmaceutical API manufacturing market include leveraging rising demand for complex biologics, ...

The market offers growth opportunities driven by increased demand for personalized medicine, advancements in cell and gene ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today reported strong growth in 2022 in both its ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...

ST Pharm, a specialized contract development and manufacturing organization (CDMO) subsidiary of Dong-A Socio Holdings, said on the 16th that it signed a contract to supply active pharmaceutical ...

BUFFALO, N.Y., Jan. 23, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and ...

Rising API prices from China and feedstock disruptions amid the West Asia crisis are tightening cost pressures on India's ...

China and India, which are the largest producers of APIs for the U.S. drug supply, also account for most of the FDA regulatory actions. Not only do quality problems at Chinese and Indian firms raise ...

On April 22, 2026, the U.S. Department of Justice and Drug Enforcement Administration’s final order rescheduling FDA-approved cannabis drug ...

What not to do with active pharmaceutical ingredient (API) batch records? Tear them out of a company logbook ahead of an FDA inspection, for one. Earlier this month, Indian drugmaker Indiana Chem-Port ...

EMPOWER'S KAI Medical Laboratory Also Supporting API Pharma With Health Canada Submission of COVID Rapid Antigen Test and Signs National Distribution Agreement VANCOUVER, BC / ACCESSWIRE / November 30 ...